Core Viewpoint - 瑞慈医疗 has made a strategic investment by purchasing a luxury residential unit in Shanghai, viewing it as a long-term investment opportunity in a prime location with significant growth potential [2][3]. Company Summary - 瑞慈医疗's indirect wholly-owned subsidiary, Shanghai Ruici Ruibo Clinic Co., Ltd., has acquired a residential unit for approximately 199 million yuan, with a total area of about 570.06 square meters [1]. - The company has paid a deposit of 30 million yuan, with the remaining 169 million yuan to be settled by November 30, funded through internal resources [1]. - The purchased property is part of the high-end residential project, 云锦东方, which has seen increased demand due to its location and celebrity residents [1]. Industry Summary - The Shanghai real estate market has experienced a contraction in new housing supply, with a year-on-year decrease of about 19% in supply area during the third quarter [3]. - Despite the reduced supply, the overall average price of new homes in Shanghai has increased by approximately 8.5% year-on-year, driven by the entry of luxury properties and relaxed price controls [3]. - The market is shifting towards a more normalized sales environment, with core areas benefiting from resource aggregation and high-quality products, leading to a recovery in sales rates to about 80% [3].